Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy

Orsi, Fernanda Andrade; De Paula, Erich V.; Santos, Fernanda de Oliveira; Teruchkin, Marcelo Melzer; Campêlo, Dirceu Hamilton Cordeiro; Mello, Tayana Teixeira; Chindamo, Maria Chiara; Macedo, Ariane Vieira Scarlatelli; Rocha, Ana Thereza; Ramacciotti, Eduardo; Nascimento, Ana Clara Kneese; Annichino-Bizzacchi, Joyce; Lourenco, Dayse Maria; Guerra, João Carlos de Campos; Rezende, Suely Meireles; Cavalheiro Filho, Cyrillo

Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy

AUTOR(ES)

Orsi, Fernanda Andrade; De Paula, Erich V.; Santos, Fernanda de Oliveira; Teruchkin, Marcelo Melzer; Campêlo, Dirceu Hamilton Cordeiro; Mello, Tayana Teixeira; Chindamo, Maria Chiara; Macedo, Ariane Vieira Scarlatelli; Rocha, Ana Thereza; Ramacciotti, Eduardo; Nascimento, Ana Clara Kneese; Annichino-Bizzacchi, Joyce; Lourenco, Dayse Maria; Guerra, João Carlos de Campos; Rezende, Suely Meireles; Cavalheiro Filho, Cyrillo

FONTE

Hematol., Transfus. Cell Ther.

DATA DE PUBLICAÇÃO

2020-10

RESUMO

ABSTRACT Hemostatic abnormalities and thrombotic risk associated with coronavirus disease 2019 (COVID-19) are among the most discussed topics in the management of this disease. The aim of this position paper is to provide the opinion of Brazilian experts on the thromboprophylaxis and management of thrombotic events in patients with suspected COVID-19, in the sphere of healthcare in Brazil. To do so, the Brazilian Society of Thrombosis and Hemostasis (BSTH) and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) have constituted a panel of experts to carefully review and discuss the available evidence about this topic. The data discussed in this document was reviewed by May 9, 2020. Recommendations and suggestions reflect the opinion of the panel and should be reviewed periodically as new evidence emerges.